Shanghai - Delayed Quote CNY
Bio-Thera Solutions, Ltd. (688177.SS)
21.72
-0.34
(-1.54%)
At close: 3:00:02 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
743,166.06
743,166.06
704,794.65
455,131.95
836,578.62
Cost of Revenue
229,541.90
229,541.90
193,298.96
190,624.58
35,599.48
Gross Profit
513,624.16
513,624.16
511,495.69
264,507.37
800,979.14
Operating Expense
1,009,646.70
1,009,646.70
904,050.04
759,151.05
716,723.34
Operating Income
-496,022.54
-496,022.54
-392,554.35
-494,643.68
84,255.80
Net Non Operating Interest Income Expense
-17,047.69
-17,047.69
-6,237.08
4,643.97
4,812.55
Pretax Income
-510,303.81
-510,303.81
-394,423.71
-480,396.73
91,044.83
Tax Provision
--
--
107.72
2.13
9,108.29
Net Income Common Stockholders
-510,303.81
-510,303.81
-394,531.43
-480,398.85
81,936.54
Basic EPS
-1.23
--
-0.95
-1.16
0.20
Diluted EPS
-1.23
--
-0.95
-1.16
0.20
Basic Average Shares
414,881.14
--
415,296.24
414,136.94
409,682.72
Diluted Average Shares
414,881.14
--
415,296.24
414,136.94
409,682.72
Total Operating Income as Reported
-508,257.96
-508,257.96
-389,666.96
-462,797.77
116,928.20
Total Expenses
1,239,188.60
1,239,188.60
1,097,349.01
949,775.63
752,322.82
Net Income from Continuing & Discontinued Operation
-510,303.81
-510,303.81
-394,531.43
-480,398.85
81,936.54
Normalized Income
-513,199.34
-513,199.34
-398,586.09
-491,534.34
72,321.31
Interest Income
3,750.46
3,750.46
4,428.58
5,031.82
5,978.48
Interest Expense
20,552.92
20,552.92
10,376.76
61.93
775.44
Net Interest Income
-17,047.69
-17,047.69
-6,237.08
4,643.97
4,812.55
EBIT
-489,750.89
-489,750.89
-384,046.95
-480,334.80
91,820.27
EBITDA
-400,364.60
-400,364.60
-298,803.05
-396,497.88
164,757.07
Reconciled Cost of Revenue
229,541.90
229,541.90
193,298.96
190,624.58
35,599.48
Reconciled Depreciation
89,386.29
89,386.29
85,243.91
83,836.92
72,936.80
Net Income from Continuing Operation Net Minority Interest
-510,303.81
-510,303.81
-394,531.43
-480,398.85
81,936.54
Total Unusual Items Excluding Goodwill
2,895.54
2,895.54
5,406.22
14,847.32
10,684.09
Total Unusual Items
2,895.54
2,895.54
5,406.22
14,847.32
10,684.09
Normalized EBITDA
-403,260.14
-403,260.14
-304,209.27
-411,345.20
154,072.98
Tax Rate for Calcs
--
--
0
0
0
Tax Effect of Unusual Items
--
--
1,351.56
3,711.83
1,068.86
12/31/2021 - 2/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade